“A Phase II trial of Nitrous Oxide for TRD”

The recent development of novel, fast acting, and durable antidepressant treatments such as Ketamine, Brexanolone, and Psilocybin has disrupted our view of the neuroscience and treatment of mood disorders. The Rapid Antidepressants Journal Club focuses on the research into the basic and translational science of how these drugs work.

Full schedule, Rapid Antidepressants Journal Club

For inquiries contact Joshua Siegel.